{"DataElement":{"publicId":"14174542","version":"1","preferredName":"Adverse Event Grading System Version Number","preferredDefinition":"The version of the classification system used to indicate the intensity of an unfavorable, unintended consequence associated with a medical treatment, intervention, or procedure.","longName":"14174540v1.00:6951332v1.00","context":"Pediatric Cancer","contextVersion":"1","DataElementConcept":{"publicId":"14174540","version":"1","preferredName":"Adverse Event Grading System","preferredDefinition":"Any unfavorable or unintended disease, sign, or symptom (including an abnormal laboratory finding) that is temporally associated with the use of a medical treatment or procedure, and that may or may not be considered related to the medical treatment or procedure. Such events can be related to the intervention, dose, route of administration, patient, or caused by an interaction with another drug(s) or procedure(s).:A morphologic classification system of malignant tumors, usually relating to disease progression and clinical outcome.  It is based upon the presence or absence of several morphologic parameters, including tumor cell necrosis, cytologic atypia, nuclear pleomorphism and mitotic figures, the architectural infiltrating patterns, and the degree of tumor cell differentiation.  Malignant tumors usually are graded I-III.","longName":"2235992v1.00:2431229v1.00","context":"Pediatric Cancer","contextVersion":"1","ObjectClass":{"publicId":"2235992","version":"1","preferredName":"Adverse Event","preferredDefinition":"Any unfavorable and unintended sign (including an abnormal laboratory finding), symptom, syndrome, or disease, temporally associated with the use of a medical product or procedure, regardless of whether or not it is considered related to the product or procedure (attribution of unrelated, unlikely, possible, probable, or definite). The concept refers to events that could be medical product related, dose related, route related, patient related, caused by an interaction with another therapy or procedure, or caused by opioid initiation or dose escalation. The term also is referred to as an adverse experience. The old term Side Effect is retired and should not be used.","longName":"C41331","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adverse Event","conceptCode":"C41331","definition":"Any unfavorable or unintended disease, sign, or symptom (including an abnormal laboratory finding) that is temporally associated with the use of a medical treatment or procedure, and that may or may not be considered related to the medical treatment or procedure. Such events can be related to the intervention, dose, route of administration, patient, or caused by an interaction with another drug(s) or procedure(s).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9860F29-74E9-7421-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-15","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-06-15","modifiedBy":"ONEDATA","dateModified":"2005-06-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2431229","version":"1","preferredName":"Grading System","preferredDefinition":"definition pending","longName":"C48224","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tumor Grading System","conceptCode":"C48224","definition":"A morphologic classification system of malignant tumors, usually relating to disease progression and clinical outcome.  It is based upon the presence or absence of several morphologic parameters, including tumor cell necrosis, cytologic atypia, nuclear pleomorphism and mitotic figures, the architectural infiltrating patterns, and the degree of tumor cell differentiation.  Malignant tumors usually are graded I-III.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"05DCE451-6154-3394-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-18","endDate":null,"createdBy":"UMLLOADER_CAP","dateCreated":"2005-11-18","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435018","version":"1","preferredName":"Clinical or Research Activity","preferredDefinition":"Any specific activity undertaken during the course of a clinical study or research protocol.","longName":"C16203","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741AE5B-831E-25C7-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"PCDC:Pediatric Cancer Data Commons","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"01563B78-A2AE-5ACE-E063-731AD00AEF31","latestVersionIndicator":"Yes","beginDate":"2023-07-25","endDate":null,"createdBy":"COLBERTM","dateCreated":"2023-07-25","modifiedBy":"COLBERTM","dateModified":"2023-07-25","changeDescription":null,"administrativeNotes":"7/25/23 Created per PCDC metadata template. mr","unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6951332","version":"1","preferredName":"Version Number","preferredDefinition":"A form or variant of a type or original; one of a sequence of copies of a program, each incorporating new modifications._A numeral or string of numerals expressing value, quantity, or identification.","longName":"6951332v1.0","context":"MCL","contextVersion":"1","type":"Non-enumerated","dataType":"NUMBER","minLength":null,"maxLength":"4","minValue":null,"maxValue":null,"decimalPlace":"2","format":"99.99","PermissibleValues":[],"ConceptualDomain":{"publicId":"2008576","version":"1","preferredName":"Data Source","preferredDefinition":"the source of patient information.","longName":"DATA_SOURCE","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BB881FE7-E125-2545-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-04-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-04-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3008885","version":"1","preferredName":"Version Number","preferredDefinition":"Version; something a little different from others of the same type; one of a sequence of copies of a program, each incorporating new modifications.:Number; a concept of quantity derived from zero and units; a numeral or string of numerals that is used for identification.","longName":"C25714:C25337","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Version","conceptCode":"C25714","definition":"A form or variant of a type or original; one of a sequence of copies of a program, each incorporating new modifications.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Number","conceptCode":"C25337","definition":"A numeral or string of numerals expressing value, quantity, or identification.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7F41B127-24BC-E668-E040-BB89AD432561","latestVersionIndicator":"Yes","beginDate":"2010-02-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2010-02-10","modifiedBy":"ONEDATA","dateModified":"2010-02-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"93C80946-F292-1FDE-E053-F662850AC9DF","latestVersionIndicator":"Yes","beginDate":"2019-09-30","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-09-30","modifiedBy":"COLBERTM","dateModified":"2022-03-21","changeDescription":"3/21/22 mr Released per Biospecimen SME.   10/10/19 jk question revised; VD withdrawn from PCA Pilot CDE set.  9/30/19 jk created for LabCas data collection and PCA-Genomic pilot project.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"12173174","version":"1","longName":"PCDC Aggregated Dictionary","context":"Pediatric Cancer","ClassificationSchemeItems":[{"publicId":"12173181","version":"1","longName":"Events","context":"Pediatric Cancer"},{"publicId":"12173218","version":"1","longName":"Adverse Events","context":"Pediatric Cancer"}]},{"publicId":"13954630","version":"1","longName":"All Pediatric Core CDEs","context":"Pediatric Cancer","ClassificationSchemeItems":[{"publicId":"14599256","version":"1","longName":"Clinical Observation","context":"Pediatric Cancer"}]}],"AlternateNames":[{"name":"AE_SYSTEM_VERSION","type":"PCDC Alt Name","context":"Pediatric Cancer"},{"name":"Grading System Version","type":"Ped Cancer Alt Name","context":"Pediatric Cancer"}],"ReferenceDocuments":[{"name":"PQT","type":"Preferred Question Text","description":"Grading System Version","url":null,"context":"Pediatric Cancer"}],"origin":"PCDC:Pediatric Cancer Data Commons","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"015694EB-17A9-67AF-E063-731AD00ACCF7","latestVersionIndicator":"Yes","beginDate":"2023-07-25","endDate":null,"createdBy":"COLBERTM","dateCreated":"2023-07-25","modifiedBy":"FINCHAMB","dateModified":"2024-02-22","changeDescription":null,"administrativeNotes":"2/22/24 Added Ped Core Alts, CSI per PCDC/MW recommendations. BF;7/25/23 Created per PCDC metadata template. mr","unresolvedIssues":null,"deletedIndicator":"No"}}